CJC-1295 w/ DAC 5mg Peptides
Engineered for research precision, this vial is built to support consistent, repeatable results across demanding laboratory workflows.
This CJC-1295 with drug affinity complex lyophilized peptide vial from Peptide Scientific Labs delivers a clean, professional presentation designed for controlled research applications. The format is a peptide lyophilized vial, containing a total strength of 5mg of the active peptide, presented to support careful handling, accurate measurements, and protocol fidelity in qualified laboratory settings.
- Each vial contains 5mg of CJC-1295 with drug affinity complex (DAC), a growth hormone–releasing hormone analog frequently studied for its extended-activity profile, stable performance characteristics, and suitability for method development under controlled laboratory conditions.
As a non-edible research material, the lyophilized presentation is selected to help protect integrity during storage and to enable predictable preparation when handled by trained professionals. In practice, researchers value its reliable behavior upon reconstitution, clear appearance when properly prepared, and compatibility with disciplined experimental techniques. The result is a dependable workpiece that supports consistent sampling, documentation, and repeatable results across runs.
Peptide Scientific Labs maintains a disciplined approach to quality at every stage. Materials are sourced with strict criteria, handled with care, and released only after verification against internal specifications. Each lot is assessed using modern analytical methods, including high-performance liquid chromatography and mass spectrometry for identity and composition, with documentation and batch traceability maintained for transparency. Certificates of Analysis are available, and packaging is selected to protect the lyophilized matrix from handling and environmental variability during transport and storage.
Trust is built on clarity: this product is intended solely for laboratory research use by qualified professionals. It is not a drug, food, or cosmetic; not for human or veterinary use; and not for household purposes. Proper storage, handling, and disposal practices are essential to maintain integrity and compliance. For researchers who value rigor, consistency, and professional presentation, CJC-1295 with drug affinity complex from Peptide Scientific Labs reflects our commitment to careful manufacturing, dependable quality controls, and the standards expected in serious research environments.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is CJC-1295 w/ DAC?
CJC-1295 with DAC is a long-acting analog of growth hormone-releasing hormone. The DAC portion refers to a drug-affinity complex added to prolong circulation time, which is why it is usually distinguished from shorter-acting GHRH analogs. It should be presented as a research peptide for endocrine signaling studies only.
What is CJC-1295 w/ DAC typically studied for?
Researchers typically study CJC-1295 with DAC for its effect on the GH/IGF-1 axis and for sustained stimulation of endogenous growth-hormone release. In FAQ copy, the useful distinction is that it is designed for longer activity than non-DAC versions, which affects how researchers think about pulse pattern and study timing.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Peptide Scientific Labs are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
This Product Contains
